De-risking the clinical development of cholesteryl ester transfer protein inhibitors: how much is good enough?

被引：6

作者：

Arsenault, Benoit J. ^{[2
]}

Boekholdt, S. Matthijs ^{[3
]}

Tardif, Jean-Claude ^{[2
]}

Kastelein, John J. P. ^{[1
]}

机构：

[1] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands

[2] Univ Montreal, Montreal Heart Inst, Quebec City, PQ, Canada

[3] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands

来源：

EUROPEAN HEART JOURNAL | 2012年 / 33卷 / 13期

关键词：

OFF-TARGET TOXICITY; ENDOTHELIAL DYSFUNCTION; TORCETRAPIB; ALDOSTERONE; DISEASE; SAFETY;

D O I：

10.1093/eurheartj/ehr408

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1548 / 1550

页数：3

共 13 条

[1] Effects of torcetrapib in patients at high risk for coronary events [J].

Barter, Philip J. ;

Caulfield, Mark ;

Eriksson, Mats ;

Grundy, Scott M. ;

Kastelein, John J. P. ;

Komajda, Michel ;

Lopez-Sendon, Jose ;

Mosca, Lori ;

Tardif, Jean-Claude ;

Waters, David D. ;

Shear, Charles L. ;

Revkin, James H. ;

Buhr, Kevin A. ;

Fisher, Marian R. ;

Tall, Alan R. ;

Brewer, Bryan .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21) :2109-2122

[2] Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease. [J].

Cannon, Christopher P. ;

Shah, Sukrut ;

Dansky, Hayes M. ;

Davidson, Michael ;

Brinton, Eliot A. ;

Gotto, Antonio M., Jr. ;

Stepanavage, Michael ;

Liu, Sherry Xueyu ;

Gibbons, Patrice ;

Ashraf, Tanya B. ;

Zafarino, Jennifer ;

Mitchel, Yale ;

Barter, Philip .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (25) :2406-2415

[3] Torcetrapib Produces Endothelial Dysfunction Independent of Cholesteryl Ester Transfer Protein Inhibition [J].

Connelly, Margery A. ;

Parry, Tom J. ;

Giardino, Edward C. ;

Huang, Zhihong ;

Cheung, Wai-man ;

Chen, Cailin ;

Cools, Frank ;

Van der Linde, Henk ;

Gallacher, David J. ;

Kuo, Gee-Hong ;

Sarich, Troy C. ;

Demarest, Keith T. ;

Damiano, Bruce P. .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2010, 55 (05) :459-468

[4] Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans - A randomized phase II dose-response study [J].

de Grooth, GJ ;

Kuivenhoven, JA ;

Stalenhoef, AFH ;

de Graaf, J ;

Zwinderman, AH ;

Posma, JL ;

van Tol, A ;

Kastelein, JJP .

CIRCULATION, 2002, 105 (18) :2159-2165

[5]

Fayad ZA, 2011, LANCET IN PRESS

[6] Prognostic value of systemic endothelial dysfunction in patients with acute coronary syndromes - Further evidence for the existence of the "vulnerable" patient [J].

Fichtlscherer, S ;

Breuer, S ;

Zeiher, AM .

CIRCULATION, 2004, 110 (14) :1926-1932

[7] Torcetrapib Induces Aldosterone and Cortisol Production by an Intracellular Calcium-Mediated Mechanism Independently of Cholesteryl Ester Transfer Protein Inhibition [J].

Hu, Xiao ;

Dietz, Jessica D. ;

Xia, Chunsheng ;

Knight, Delvin R. ;

Loging, William T. ;

Smith, Andrew H. ;

Yuan, Haodan ;

Perry, David A. ;

Keiser, Joan .

ENDOCRINOLOGY, 2009, 150 (05) :2211-2219

[8] Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia [J].

Kastelein, John J. P. ;

van Leuven, Sander I. ;

Burgess, Leslie ;

Evans, Greg W. ;

Kuivenhoven, Jan A. ;

Barter, Philip J. ;

Revkin, James H. ;

Grobbee, Diederick E. ;

Riley, Ward A. ;

Shear, Charles L. ;

Duggan, William T. ;

Bots, Michiel L. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (16) :1620-1630

[9]

Luscher TF, 2011, VASCULAR EFFECTS SAF, V28

[10] Torcetrapib impairs endothelial function in hypertension [J].

Simic, Branko ;

Hermann, Matthias ;

Shaw, Sidney G. ;

Bigler, Laurent ;

Stalder, Urs ;

Doerries, Carola ;

Besler, Christian ;

Luescher, Thomas F. ;

Ruschitzka, Frank .

EUROPEAN HEART JOURNAL, 2012, 33 (13) :1615-U53

← 1 2 →